SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2024 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: technetium who wrote (87)6/8/2024 12:47:26 PM
From: technetium2 Recommendations

Recommended By
BulbaMan
kathleen

  Read Replies (1) of 97
 
Bare bones report:

CNSP had a 50:1 reverse split, which is rather dire.

finance.yahoo.com
“HOUSTON, TX / ACCESSWIRE / June 3, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced a 1-for-50 reverse split of its common stock, effective at 4:01 PM ET on June 4, 2024.

Beginning on June 5, 2024, the Company's common stock will continue to trade on The Nasdaq Capital Market ("Nasdaq") on a split adjusted basis under the trading symbol "CNSP", but will trade under the following new CUSIP number: 18978H300. The reverse stock split is primarily intended to increase the Company's per share trading price and bring the Company into compliance with the Nasdaq's listing requirement regarding minimum share price.”

Actually, if do a web search on
“recent biotech reverse stock splits”
For the last week (or pick your date range,) it seems to be a popular trend these days.

Report Time Ranges











From

To

















Recent

5/31/24

6/7/24

















YTD

12/31/2023









Index Portfolios’ Performance









Symbol

Recent P/L

Recent %

YTD P/L

















^IXIC

$2,652.05

2.4%

$14,134.45

















^NBI

$2,302.63

2.3%

$3,000.77

















^SPSIBI

$2,574.68

2.6%

$2,230.02









Share Performance

Recent Performance

YTD Performance



Top Five



Bottom Five



Top Five



Bottom 5

Symbol

P/L / Initial Price

Symbol

P/L / Initial Price

Symbol

YTD P/L / Initial Price

Symbol

YTD P/L/ Initial Price

NVAX

65.4%

VKTX

-33.7%

NVAX

278.5%

CNSP

-92.0%

LRMR

34.9%

CBUS

-18.4%

JSPR

210.8%

GLYC

-89.1%

REPL

31.2%

JSPR

-18.3%

VKTX

200.9%

AMLX

-88.0%

AFMD

28.6%

TNYA

-17.6%

CU6.AX

164.1%

PACB

-79.5%

TWST

23.2%

OCUL

-17.0%

PYXS

111.1%

RVNC

-69.3%

Average and Median Portfolio Performance



Recent P/L







YTD P/L







Avg.

Median







Avg

Median







-$1,108.37

$467.64

TRACE I11



$4,931.88

-$2,837.56

TECHNETIUM

Top Seven Portfolio Performances

Top Recent Performers

Top YTD Performers

Contestant (Prev. Rank)

Recent P/L

P/L vs. ^SPSIBI

YTD P/L (Rank)

Contestant (Prev. Rank)

YTD P/L

vs. Top Portfolio

P/L vs. ^SPSIBI

Rec. P/L (Rank)

1 - ALONER (4)

$4,683.85

$2,109.17

-$5,298.45 (13)

1 - BULBAMAN (1)

$73,798.83

——

$71,568.81

-$4,528.94 (14)

2 - TOMATO (10)

$3,384.30

$809.61

$30,534.62 (3)

2 - ERIKOTTO (2)

$33,181.52

$40,617.32

$30,951.49

$799.01 (6)

3 - NOTABOT (13)

$3,135.69

$561.01

-$1,215.09 (8)

3 - TOMATO (4)

$30,534.62

$43,264.21

$28,304.60

$3,384.30 (2)

4 - DEW_DILIGENCE (6)

$1,732.96

-$841.73

$9,318.60 (5)

4 - BLADERUNNER (3)

$24,510.07

$49,288.77

$22,280.04

-$7,290.49 (16)

5 - A. J. MULLEN (7)

$1,717.57

-$857.11

-$23,287.53 (17)

5 - DEW_DILIGENCE (6)

$9,318.60

$64,480.23

$7,088.58

$1,732.96 (4)

6 - ERIKOTTO (2)

$799.01

-$1,775.67

$33,181.52 (2)

6 - JACK HARTMANN (5)

$6,776.92

$67,021.91

$4,546.90

-$1,658.13 (10)

7 - DART LANZER (14)

$591.31

-$1,983.37

-$3,797.26 (11)

7 - TRACE I11 (10)

-$793.08

$74,591.91

-$3,023.10

$467.64 (9)

8 - JR_95 (8)

$582.18

-$1,992.51

-$18,869.47 (15)

8 - NOTABOT (12)

-$1,215.09

$75,013.92

-$3,445.12

$3,135.69 (3)

Top Portfolios’ Contents

Top Recent Performance Portfolio (ALONER)

Top YTD Performance Portfolio (BULBAMAN)

Symbol (Rank)

Initial Allocation

Value/Total | ROI

YTD Stock P/L

Recent Stock P/L

% Current Price Change for $1,000 P/L

Symbol (Rank)

Initial Allocation

Value/Total | ROI

YTD Stock P/L

Recent Stock P/L

% Current Price Change for $1,000 P/L

ACRS

5.00%

5.1% | -3.8%

-$190.48

-$95.24

20.8%

CU6.AX

20.00%

30.4% | 164.1%

$32,811.25

$568.88

1.9%

AFMD

20.00%

20.7% | -1.8%

-$352.00

$5,728.00

5.1%

CYTH

10.00%

4.6% | -20.8%

-$2,075.47

-$125.79

12.6%

CDTX

20.00%

17.1% | -19.1%

-$3,828.72

$188.92

6.2%

LRMR

10.00%

12.1% | 110.8%

$11,076.92

$3,494.51

4.7%

CLSD

5.00%

5.5% | 4.3%

$213.68

-$769.23

19.2%

PMN

10.00%

8.9% | 53.9%

$5,391.30

-$626.09

6.5%

CRVS

20.00%

24.4% | 15.3%

$3,068.18

-$1,477.27

4.3%

SNGX

10.00%

1.8% | -68.9%

-$6,891.45

-$1,101.97

32.2%

KZIA

20.00%

12.0% | -43.2%

-$8,646.19

-$477.82

8.8%

TCON

10.00%

1.9% | -67.4%

-$6,744.72

-$399.77

30.7%

MRNA

5.00%

8.0% | 51.8%

$2,592.26

$425.34

13.2%

TLX.AX

15.00%

14.4% | 67.3%

$10,102.03

-$1,284.97

4.0%

TWST

5.00%

7.2% | 36.9%

$1,844.82

$1,161.15

14.6%

VKTX

15.00%

26.0% | 200.9%

$30,128.96

-$5,053.73

2.2%

















































Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext